Ms. Moira Ong reports

PROMINO ANNOUNCES SETTLEMENTS AND AMENDMENTS OF CONVERTIBLE DEBENTURES

Promino Nutritional Sciences Inc. has agreed to settle $373,910 in principal and accrued interest of convertible debentures through the issuance of 5,341,566 common shares at a deemed issue price of seven cents. In addition, certain convertible debentures, originally issued on June 30 and July 14, 2023, having an aggregate principal amount of $711,500, have been amended as follows: (1) Maturity dates have been extended for a further two-year period to June 30 and July 14, 2027; and (2) conversion prices have been amended from 30 cents per unit to seven cents per common share.

About Promino Nutritional Sciences Inc.

Promino is a Canadian innovation company focused on science-based, clinically proved nutrition for muscle health and recovery. Its core product, Rejuvenate Muscle Health, is a clinically researched proprietary amino acid formula designed to rebuild, restore and rejuvenate muscle tissue.

We seek Safe Harbor.